Hypersensitivity reactions to complementary and alternative medicine products

Current Pharmaceutical Design

Volumn 12, Issue 26, 2006, Pages 3393-3399

  Ventura, Maria Teresa ^a   Viola, Marinella ^b   Calogiuri, Gianfranco ^c   Gaeta, Francesco ^b   Pesole, Oronzo ^c   Romano, Antonino ^b,d  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c IRCCS   (Italy)

^d OASI RESEARCH INSTITUTE IRCCS   (Italy)

Author keywords

Contact dermatitis; Herbal remedies; Hypersensitivity reactions; Metals; Patch tests; Specific IgE

Indexed keywords

ADRENALIN; ARNICA MONTANA EXTRACT; CASSIA EXTRACT; CHAMOMILE; CITRONELLAL; CITRUS BERGAMIA EXTRACT; CITRUS FRUIT EXTRACT; CITRUS HYSTRIX EXTRACT; CLOVE OIL; ECBALIUM ELATERIUM EXTRACT; ECHINACEA ANGUSTIFLORA EXTRACT; ESSENTIAL OIL; GINKGO BILOBA EXTRACT; HERBACEOUS AGENT; HISTAMINE; HYPERICUM PERFORATUM EXTRACT; IMMUNOGLOBULIN E; INULA HELENIUM EXTRACT; LAVENDER OIL; LEMON OIL; METAL DERIVATIVE; PHOTOSENSITIZING AGENT; PLANT EXTRACT; PREDNISOLONE; PROPOLIS; PSORALEA CORYFOLIA EXTRACT; TEA TREE OIL; TRYPTASE; UNCLASSIFIED DRUG; UNINDEXED DRUG; YLANG YLANG OIL;

ALTERNATIVE MEDICINE; AMNESIA; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; AROMATHERAPY; ASTHMA; BASOPHIL; CELLULAR IMMUNITY; CITRUS BERGAMIA; CITRUS FRUIT; CITRUS HYSTRIX; CLINICAL FEATURE; CONTACT DERMATITIS; DELAYED HYPERSENSITIVITY; DEMENTIA; DEPRESSION; DIAGNOSTIC PROCEDURE; DISEASE EXACERBATION; DRUG HYPERSENSITIVITY; ECBALIUM ELATERIUM; ECZEMA; ELECAMPANE; HERPES; HUMAN; HYPERSENSITIVITY; IMMEDIATE TYPE HYPERSENSITIVITY; INULA; LYMPHOCYTE TRANSFORMATION TEST; MACULOPAPULAR RASH; MAST CELL; MEDICINAL PLANT; NONHUMAN; PATCH TEST; PATHOGENESIS; PHARYNGITIS; PHOTOSENSITIVITY; PHOTOSENSITIZATION; PRIORITY JOURNAL; PSORALEA; RESPIRATORY TRACT DISEASE; REVIEW; RHINITIS; SINUSITIS; SKIN TEST; STEVENS JOHNSON SYNDROME; URTICARIA;

COMPLEMENTARY THERAPIES; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; MALE; PLANT PREPARATIONS;

EID: 33748555856     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161206778194079     Document Type: Review

References (79)

1. Bielory L. 'Complementary and alternative medicine' population based studies: a growing focus on allergy and asthma. Allergy 2002; 57: 655-8.
2. Fisher P, Ward A. Complementary medicine in Europe. BMJ 1994; 309: 107-11.
3. Eisenberg DM, Davis RB, Ettner SL, Appel MS, Wilkey S, Van Rompay M, et al. Trends in alternative medicine use in United States, 1990-1997. JAMA 1998; 280: 1569-75.
4. MacLennan AH, Wilson DH, Taylor AW. Prevalence and cost of alternative medicine in Australia. Lancet 1996; 347: 569-73.
5. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco T. Unconventional medicine in the United States. N Engl J Med 1993; 328: 246-52.
6. Ernst E, White A. The BBC survey of the complementary medicine use in the UK. Complement Ther Med 2000; 8: 32-6.
7. Schäfer T, Riehle A, Wichmann H-E, Ring J. Alternative medicine in allergies - prevalence, patterns of use, and costs. Allergy 2002; 57: 694-700.
8. Astin JA. Why patients use alternative medicine: results of a national study. JAMA 1998; 279: 1548-53.
9. Bielory L. Complementary and alternative interventions in asthma, allergy, and immunology. Ann Allergy Asthma Immunol 2004; 93(2 Suppl 1): S45-S54.
10. Senna G, Passalacqua G, Crivellaro M, Bonadonna P, Gani F, Dorizzi R, et al. Unconventional medicine: a risk of undertreatment of allergic patients. Allergy 1999; 54: 1117-9.
11. Barnes J, Mills SY, Abbot NC, Willoughby M, Ernst E. Different standards for reporting ADRs to herbal remedies and conventional OTC medicines: face-to-face interviews with 515 users of herbal remedies. Br J Clin Pharmacol 1998; 45: 496-500.
12. Passalacqua G, Compalati E, Schiappoli M, Senna G. Complementary and alternative medicine for the treatment and diagnosis of asthma and allergic diseases. Monaldi Arch Chest Dis 2005; 63: 47-54.
13. Niggermann B, Grüber C. Side-effects of complementary and alternative medicine. Allergy 2003; 58: 707-16.
14. Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004; 113: 832-6.
15. Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med 2003; 139: 683-93.
16. Simpson EL, Law SV, Storrs FJ. Prevalence of botanical extract allergy in patients with contact dermatitis. Dermatitis 2004; 15: 67-72.
17. Thomson KF, Wilkinson SM. Allergic contact dermatitis to plant extracts in patients with cosmetic dermatitis. Br J Dermatol 2000; 142: 84-8.
18. Apted JH. Contact dermatitis associated with the use of tea-tree oil. Australas J Dermatol 1991; 32: 177.
19. Knight TE, Hausen BM. Melaleuca oil (tea tree oil) dermatitis. J Am Acad Dermatol 1994; 30: 423-7.
20. de Groot AC. Airborne allergic contact dermatitis from tea tree oil. Contact Dermatitis 1996; 35: 304-5.
21. de Groot AC, Weyland JW. Systemic contact dermatitis from tea tree oil. Contact Dermatitis 1992; 27: 279-80.
22. Perret CM, Evans AV, Russel-Jones R. Tea tree oil dermatitis associated with linear IgA disease. Clin Exp Dermatol 2003; 28: 167-70.
23. van der Valk PG, de Groot AC, Bruynzeel DP, Coenraads PJ, Weijland JW. Allergic contact eczema due to 'tea tree' oil. Ned Tijdschr Geneeskd 1994; 138: 823-5.
24. Selvaag E, Holm J-O, Thune P. Allergic contact dermatitis in an aroma therapist with multiple sensitizations to essential oils. Contact Dermatitis 1995; 33: 354-5.
25. Greig JE, Carson CF, Stuckey MS, Riley TV. Skin sensitivity testing for tea tree oil - a report for the Rural Industries Research and Development Corporation. Rural Industries Research and Development Corporation, Barton Act, Australia; 1999: report No. 99.
26. Pratt M. North American Contact Dermatitis Group, personal communication, January 11, 2004.
27. Crawford GH, Sciacca JR, James WD. Tea tree oil: cutaneous effects of the extracted oil of Melaleuca alternifolia. Dermatitis 2004; 15: 59-66.
28. Hausen BM. A 6-year experience with Compositae mix. Am J Contact Dermatitis 1996; 7: 94-9.
29. Paulsen E, Andersen KE, Hausen BM. An 8-year experience with routine SL mix patch testing supplemented with Compositae mix in Denmark. Contact Dermatitis 2001; 45: 29-35.
30. Jovanovic M, Poljacki M, Duran V, Vujanovic L, Sente R, Stojanovic S. Contact allergy to Compositae plants in patients with atopic dermatitis. Med Pregl 2004; 57: 209-18.
31. Hausen BM. Arnica allergy. Hautarzt 1980; 31: 10-7.
32. Mateo MP, Velasco M, Miquel FJ, de la Cuadra J. Erythema-multiforme-like eruption following contact dermatitis from sesquiterpene lactones in herbal medicine. Contact Dermatitis 1995; 33: 449-50.
33. Paulsen E, Andersen KE, Hausen BM. Sensitization and cross-reaction patterns in Danish Compositae-allergic patients. Contact Dermatitis 2001; 45: 197-204.
34. Subiza J, Subiza JL, Hinojosa M, Garcia R, Jerez M, Valdivieso R, et al. Anaphylactic reactions after the ingestion of chamomile tea: a study of cross-reactivity with other composite pollens. J Allergy Clin Immunol 1989; 84: 353-8.
35. Jensen-Jarolim E, Reider N, Fritsch R, Breiteneder H. Fatal outcome of anaphylaxis to camomile-containing enema during labor: a case study. J Allergy Clin Immunol 1998; 102: 1041-2.
36. Mullins RJ, Heddle R. Adverse reactions associated with echinacea: the Australian experience. Ann Allergy Asthma Immunol 2002; 88: 42-51.
37. Soon SL, Crawford RI. Recurrent erythema nodosum associated with Echinacea herbal therapy. J Am Acad Dermatol 2001; 44: 298-9.
38. Cardinali C, Francalanci S, Giomi B, Caproni M, Sertoli A, Fabbri P. Contact dermatitis from Rhus toxicodendron in a homeopathic remedy. J Am Acad Dermatol 2004; 50: 150-1.
39. Chiu AE, Lane AT, Kimball AB. Diffuse morbilliform eruption after consumption of gingko biloba supplement. J Am Acad Dermatol 2002; 46: 145-6.
40. Bernstein IL, Gruchalla RS, Lee RE, Nicklas RA, Dykewicz MS, Shepherd GM, et al. Disease management of drug hypersensitivity: A practice parameter. Ann Allergy Asthma Immunol 1999; 83: 665-700.
41. Aberer W, Bircher A, Romano A, Blanca M, Campi P, Fernandez J, et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 2003: 58: 854-63.
42. Mochitomi Y, Inoue A, Kawabata H, Ishida S, Kanzaki T. Stevens-Johonson syndrome caused by a health drink (Eberu®) containing ophiopogonis tuber. J Dermatol 1998; 25: 662-5.
43. Monk B. Severe cutaneous reactions to alternative remedies. BMJ 1986; 293: 665-6.
44. Kou D, Ong CN. Phytophotodermatitis due to the application of Citrus hystrix as a folk remedy. Br J Dermatol 1999; 140: 737-8.
45. Golsch S, Vocks E, Rakoski J, Brockow K, Ring J. Reversible increase in photosensitivity to UV-B caused by St. John's Wort extract. Hautarzt 1997; 48: 249-52.
46. Bove GM. Acute neuropathy after exposure to sun in a patient treated with St John's Wort. Lancet 1998; 352: 1121-2.
47. Maurice PD, Cream JJ. The dangers of herbalism. BMJ 1989; 299: 1204.
48. Kaddu S, Kerl H, Wolf P. Accidental bullous phototoxic reactions to bergamot aromatherapy oil. J Am Acad Dermatol 2001; 45: 458-61.
49. Price S, Price L. Aromatherapy for health professionals. Edinburgh: Churchill Livingstone, 1995.
50. Crawford GH, Katz KA, Ellis E, James WD. Use of aromatherapy products and increased risk of hand dermatitis in massage therapists. Arch Dermatol 2004; 140: 991-6.
51. Kavli G, Forde OH. Hand dermatoses in Tromso. Contact Dermatitis 1984; 10: 174-7.
52. Susitaival P, Husman L, Horsmanheimo M, Notkola V, Husman K. Prevalence of hand dermatoses among Finnish farmers. Scand J Work Environ Health 1994; 20: 206-12.
53. Singgih SI, Lantinga H, Nater JP, Woest TE, Kruyt-Gaspersz JA. Occupational hand dermatoses in hospital cleaning personnel. Contact Dermatitis 1986; 14: 14-9.
54. Meding B, Swanbeck G. Prevalence of hand eczema in an industrial city. Br J Dermatol 1987; 116: 627-34.
55. Crivellaro MA, Senna G, Riva G, Cislaghi C, Falàgiani P, Canonica GW, et al. Pollen mixture used as health food may be a harmful source of allergens. J Investig Allergol Clin Immunol 2000; 10: 310-1.
56. Eray O, Tuncok Y, Eray E, Gunerli A, Guven H. Severe uvular angioedema caused by intranasal administration of Ecbalium elaterium. Vet Human Toxicol 1999; 41: 376-8.
57. Kloutsos G, Balatsouras DG, Kaberos AC, Kandiloros D, Ferekidis E, Economou C. Upper airway edema resulting from use of Ecbalium elaterium. Laryngoscope 2001; 111: 1652-5.
58. Lee SK, Cho HK, Cho SH, Kim SS, Nahm DH, Park HS. Occupational asthma and rhinitis caused by multiple herbal agents in a pharmacist. Ann Allergy Asthma Immunol 2001; 86: 469-74.
59. Park HK, Jeon SG, Kim TB, Kang HR, Chang YS, Kim YK, et al. Occupational asthma and rhinitis induced by a herbal medicine, Wonji (Polygala tenuifolia). J Korean Med Sci 2005; 20: 46-9.
60. Subiza J, Subiza JL, Escribano PM, Hinojosa M, Garcia R, Jerez M, et al. Occupational asthma caused by Brazil ginseng dust. J Allergy Clin Immunol 1991; 88: 731-6.
61. Cartier A, Malo JL, Labrecque M. Occupational asthma due to liquorice roots. Allergy 2002; 57: 863.
62. White JC. Dermatitis venenata, Boston: Cupples & Hurd 1887: 127-31.
63. Garrido Fernandez S, Arroabarren Aleman E, Garcia Figueroa BE, Goienetxe Fagoaga E, Olaguibel Rivera JM, Tabar Purroy AI. Direct and airborne contact dermatitis from propolis in beekeepers. Contact Dermatitis 2004; 50: 320-1.
64. Gulbahar O, Ozturk G, Erdem N, Kazandi AC, Kokuludag A. Psoriasiform contact dermatitis due to propolis in a beekeeper. Ann Allergy Asthma Immunol 2005; 94: 509-11.
65. Winkler A. Dermatitis caused by resin of poplar. Dermatol Wochenschr 1956; 133: 81-7.
66. Camarasa G. Occupational dermatitis from beeswax. Contact Dermatitis 1975; 1: 124.
67. Monti M, Berti E, Carminati G, Cusini M. Occupational and cosmetic dermatitis from propolis. Contact Dermatitis 1983; 9: 163.
68. Downs A, Sansom J. Occupational contact dermatitis due to propolis. Contact Dermatitis 1998; 38: 359-60.
69. Hsu CY, Chiang WC, Weng TI, Chen WJ, Yuan A. Laryngeal edema and anaphylactic shock after topical propolis use for acute pharyngitis. Am J Emerg Med 2004; 22: 432-3.
70. van Ulsen J, Stolz E, van Joost TH. Chromate dermatitis from a homeopathic drug. Contact Dermatitis 1988; 18: 56-7.
71. Conde-Salazar L, Valks R, Malfeito JE, García C, Ledo S. Contact dermatitis from the staples of neuroreflexotherapy. Contact Dermatitis 2004; 51: 217-8.
72. Audicana M, Bernedo N, Gonzalez I, Muñoz E, Fernández E, Gastaminza G. An unusual case of baboon syndrome due to mercury present in a homeopathic medicine. Contact Dermatitis 2001; 45: 185.
73. de Smet PA, Pegt GW, Meyboom RH. Acute circulatory shock following administration of the non-regular enzyme preparation Wobe-Mugos. Ned Tijdschr Geneeskd 1991; 135: 2341-4.
74. Staab D, von Rueden U, Kehrt R, Erhart M, Wenninger K, Kamtsiuris P, et al. Evaluation of a parental training program for the management of childhood atopic dermatitis. Pediatr Allergy Immunol 2002; 13: 84-90.
75. Bork K. Cutaneous Side-effects of Drugs. Philadelphia: Saunders, 1988.
76. Ernst E. Serious adverse effects of unconventional therapies for children and adolescents: a systematic review of recent evidence. Eur J Pediatr 2003; 162: 72-80.
77. Cetkovic-Cvrlje M, Tibbles HE. Therapeutic potential of Janus kinase 3 (JAK3) inhibitors. Curr Pharm Des 2004; 10(15): 1767-84.
78. Johnston GA. GABA(A) receptor channel pharmacology. Curr Pharm Des 2005; 11(15): 1867-85.
79. Tsang SY, Xue H. Development of effective therapeutics targeting the GABAA receptor: naturally occurring alternatives. Curr Pharm Des 2004; 10(9): 1035-44.